Nucleotide sequences coding for a human protein with angiogenesis regulative properties
CA 2092533 C · Owner: Consiglio Nazionale Delle Ricerche · Inventors: Persico, Maria; Maglione, Domenico
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
A cDNA sequence coding for a human protein having regulative properties of angiogenesis has been isolated and sequenced. Expression vector containing such sequence have been constructed and after transformation of host cells, the synthesis of the related protein has been obtained. Such protein called PIGF can be employed both in the tumoral immunologic and diagnostic field and in the therapeutic field for pathologies related to the formation of vessels, as for instance the healing of wounds and so on.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed September 26, 1991 and granted May 28, 2002. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended September 26, 2011.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by September 26, 2013.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.